Jane Street
MYGN icon

Jane Street’s Myriad Genetics MYGN Stock Holding History

Jane Street’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,400
Closed -$207K – 10574
2021
Q3 		$207K Sell
6,400
-300
-4% -$9.96K ﹤0.01% 8788
2021
Q2 		$205K Buy
+6,700
New +$194K ﹤0.01% 8778
2021
Q1 		– Sell
-12,200
Closed -$241K – 9418
2020
Q4 		$241K Buy
+12,200
New +$197K ﹤0.01% 6721
2020
Q3 		– Sell
-13,500
Closed -$153K – 7642
2020
Q2 		$153K Buy
+13,500
New +$192K ﹤0.01% 6537
2019
Q4 		– Sell
-9,100
Closed -$261K – 5510
2019
Q3 		$261K Sell
9,100
-2,400
-21% -$69.9K ﹤0.01% 4323
2019
Q2 		$319K Buy
+11,500
New +$325K ﹤0.01% 4124

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's MYGN Position: Q2 2026 in Review

Jane Street sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 1,202,531 shares — an estimated $5.41M sold.

Jane Street first reported a position in MYGN in Q4 2013 and held it in 30 quarters. The position peaked at $5.41M in Q1 2026. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Jane Street reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 1,202,531 Myriad Genetics shares in Q2 2026, an estimated $5.41M.
  • Jane Street first reported a position in Myriad Genetics in Q4 2013 and held it in 30 quarters.
  • Jane Street's Myriad Genetics position peaked at $5.41M in Q1 2026.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.